AC
RCUS icon

Athanor Capital’s Arcus Biosciences RCUS Stock Holding History

Athanor Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-22,053
Closed -$619K – 695
2021
Q1 		$619K Sell
22,053
-3,408
-13% -$119K 0.01% 432
2020
Q4 		$661K Buy
25,461
+14,507
+132% +$351K 0.02% 408
2020
Q3 		$188K Buy
+10,954
New +$245K 0.01% 496
2020
Q1 		– Sell
-26,300
Closed -$266K – 304
2019
Q4 		$266K Buy
+26,300
New +$221K 0.01% 324
2019
Q3 		– Sell
-15,900
Closed -$126K – 223
2019
Q2 		$126K Buy
+15,900
New +$159K 0.02% 138

Other funds holding RCUS

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Athanor Capital's RCUS Position: Q2 2021 in Review

Athanor Capital sold out of Arcus Biosciences (RCUS) in Q2 2021, closing a stake of 22,053 shares — an estimated $619K sold.

Athanor Capital first reported a position in RCUS in Q2 2019 and held it in 5 quarters. The position peaked at $661K in Q4 2020. 130 funds tracked by Wall St. Rank hold RCUS as of Q2 2021.

  • Athanor Capital reported no remaining Arcus Biosciences position as of Q2 2021 after selling out during the quarter.
  • Athanor Capital sold 22,053 Arcus Biosciences shares in Q2 2021, an estimated $619K.
  • Athanor Capital first reported a position in Arcus Biosciences in Q2 2019 and held it in 5 quarters.
  • Athanor Capital's Arcus Biosciences position peaked at $661K in Q4 2020.
  • 130 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2021.

Based on Athanor Capital's 13F filing for Q2 2021, filed 16 Aug 2021.